Kovaltry
Payments companies reported to CMS as associated with Kovaltry. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Kovaltry, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Kovaltry
These are the largest totals companies reported as associated with Kovaltry. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Shveta Gupta | Orlando, FL | Pediatric Hematology-Oncology | $1,902.00 |
| Maissaa Janbain | New Orleans, LA | Hematology & Oncology | $1,310.00 |
| Doris Quon | Los Angeles, CA | Hematology (Internal Medicine) | $363.20 |
| Christopher Chan | Los Angeles, CA | Family | $212.94 |
| Ming Lim | Charleston, SC | Hematology & Oncology | $172.96 |
| Dwight Generoso | Las Vegas, NV | Family | $166.43 |
| Daisy Cortes | Las Vegas, NV | Pediatric Hematology-Oncology | $143.88 |
| Joseph Lasky | Las Vegas, NV | Pediatric Hematology-Oncology | $140.75 |
| Tracey Gaslin | Louisville, KY | Family | $123.23 |
| Lance Sieger | Torrance, CA | Pediatric Hematology-Oncology | $114.69 |
Prescribed Kovaltry?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.